Pfizer, Merck shares smoking hot in 2018 despite doldrums for overall biopharma sector

Key oncology wins helped drive Pfizer and Merck to the top of the Dow in 2018, which could very well lead investors to assume life sciences will be a safe place to park their money this year. Not so fast, some experts say.